National Standard India Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of National Standard (India) Ltd is ₹ 102.5 as of 23 Oct 15:30 . The P/E Ratio of National Standard (India) Ltd changed from 97.2 on March 2021 to 278.4 on March 2026 . This represents a CAGR of 19.17% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of National Standard (India) Ltd changed from ₹ 1075 crore on March 2021 to ₹ 2689 crore on March 2026 . This represents a CAGR of 16.51% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of National Standard (India) Ltd for the Sep '26 is ₹ 4.59 crore as compare to the Jun '26 revenue of ₹ 3.47 crore. This represent the growth of 32.28% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of National Standard (India) Ltd for the Sep '26 is ₹ 4.46 crore as compare to the Jun '26 ebitda of ₹ 3.39 crore. This represent the growth of 31.56% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of National Standard (India) Ltd changed from ₹ 2.64 crore to ₹ 3.34 crore over 10 quarters. This represents a CAGR of 9.86% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The Dividend Payout of National Standard (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About National Standard (India) Ltd

National Standard (India) Limited (Formerly known National-Standard Duncan Limited) was incorporated on August 20, 1962.
The Company attained a new change in name to 'National Standard (India) Limited' from National-Standard Duncan Limited in September, 2003.
At present, Company is engaged in Real Estate Development.
Prior to this, the Company manufactured bead-wire for tyres and other types of specialised wires.
It was formed and collaborated between National Standard Company, US, and Indian Agency House of Duncan Brothers & Co., Calcutta. The Wire Division is constructing a wire plant at Baddi, Himachal Pradesh.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of National Standard (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, National Standard (India) Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of National Standard (India) Ltd is 205 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of National Standard (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of National Standard (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for National Standard (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the National Standard (India) Ltd stock price is INR ₹102.5. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of National Standard (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of National Standard (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.